Alchemical approach performance in calculating the ligand-binding free energy

Son Tung Ngo, Quynh Mai Thai, Trung Hai Nguyen, Nguyen Ngoc Tuan, T. Ngoc Han Pham, Huong T. T. Phung and Duong Tuan Quang

RSC Adv., 2024, 14, 14875
DOI: 10.1039/D4RA00692E

The impact of SARS-CoV-2 3CL protease mutations on nirmatrelvir inhibitory efficiency. Computational insights into potential resistance mechanisms

Carlos A. Ramos-Guzmán, Milorad Andjelkovic, Kirill Zinovjev, J. Javier Ruiz-Pernía and Iñaki Tuñón

Chem. Sci., 2023, 14, 2686
DOI: 10.1039/D2SC06584C

The stable “F–SO2+” donor provides a mild and efficient approach to nitriles and amides

Yin Cui, Yiyong Zhao, Junjie Shen, Guofu Zhang and Chengrong Ding

RSC Adv., 2022, 12, 33064
DOI: 10.1039/D2RA05890A

Insights into the binding and covalent inhibition mechanism of PF-07321332 to SARS-CoV-2 Mpro

Son Tung Ngo, Trung Hai Nguyen, Nguyen Thanh Tung and Binh Khanh Mai

RSC Adv., 2022, 12, 3729
DOI: 10.1039/D1RA08752E

Characterizing the ligand-binding affinity toward SARS-CoV-2 Mproviaphysics- and knowledge-based approaches

Son Tung Ngo, Trung Hai Nguyen, Nguyen Thanh Tung, Van V. Vu, Minh Quan Pham and Binh Khanh Mai

Phys. Chem. Chem. Phys., 2022, 24, 29266
DOI: 10.1039/D2CP04476E

Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review

Lei Zhao, Song Li and Wu Zhong

Front. Pharmacol., 2022, 13
DOI: 10.3389/fphar.2022.840639

How Reproducible Are QM/MM Simulations? Lessons from Computational Studies of the Covalent Inhibition of the SARS-CoV-2 Main Protease by Carmofur

Goran Giudetti, Igor Polyakov, Bella L. Grigorenko, Shirin Faraji, Alexander V. Nemukhin and Anna I. Krylov

J. Chem. Theory Comput., 2022, 18, 5056
DOI: 10.1021/acs.jctc.2c00286

Recent progress on drugs discovery study for treatment of COVID-19: repurposing existing drugs and current natural bioactive molecules

Ika Oktavianawati, Mardi Santoso, Mohd Fadzelly Abu Bakar, Yong-Ung Kim and Sri Fatmawati

Appl Biol Chem, 2023, 66
DOI: 10.1186/s13765-023-00842-x

Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors

Hoshin Kim, Darin Hauner, Joseph A. Laureanti, Kruel Agustin, Simone Raugei and Neeraj Kumar

Sci Rep, 2022, 12
DOI: 10.1038/s41598-022-23570-6

Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure–Activity Relationship Insights and Evolution Perspectives

Gabriele La Monica, Alessia Bono, Antonino Lauria and Annamaria Martorana

J. Med. Chem., 2022, 65, 12500
DOI: 10.1021/acs.jmedchem.2c01005

The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations

Ryan P. Joyce, Vivian W. Hu and Jun Wang

Med Chem Res, 2022, 31, 1637
DOI: 10.1007/s00044-022-02951-6

Design, Synthesis, Evaluation, and Molecular Dynamics Simulation of SARS-CoV-2 Mpro Inhibitors

Qinghua Yang, Keli Zong, Xu Zhao, Fenghua Zhang, Fei Li and Xingzhou Li

ACS Med. Chem. Lett., 2025, 16, 668
DOI: 10.1021/acsmedchemlett.5c00065

Template-Based Docking Using Automated Maximum Common Substructure Identification with EnzyDock: Mechanistic and Inhibitor Docking

Renana Schwartz, Amit Hadar-Volk, Kwangho Nam and Dan T. Major

J. Chem. Inf. Model., 2025, 65, 5596
DOI: 10.1021/acs.jcim.5c00201

Structural Basis for the Acylation Reaction of Alphacoronavirus 3C-like Protease

Junwei Zhou, Jiyao Chen, Peng Sun, Gang Ye, Yuanqing Wang, Runhui Qiu, Zhixiang Yang, Dengguo Wei, Guiqing Peng, Liurong Fang and Shaobo Xiao

ACS Catal., 2024, 14, 8330
DOI: 10.1021/acscatal.4c01159

Revealing the impact of active site residues in modeling the inhibition mechanism of SARS-Cov-2 main protease by GC373

Mohamed M. Aboelnga, Maya Petgrave, Subha Kalyaanamoorthy and Aravindhan Ganesan

Computers in Biology and Medicine, 2025, 187, 109779
DOI: 10.1016/j.compbiomed.2025.109779

Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2

Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei and Guo-Wei Wei

Chem. Rev., 2022, 122, 11287
DOI: 10.1021/acs.chemrev.1c00965

Pomotrelvir and Nirmatrelvir Binding and Reactivity with SARS‐CoV‐2 Main Protease: Implications for Resistance Mechanisms from Computations

Johanna Schillings, Carlos A. Ramos‐Guzmán, J. Javier Ruiz‐Pernía and Iñaki Tuñón

Angew Chem Int Ed, 2024, 63
DOI: 10.1002/anie.202409527

How SARS-CoV-2 Alters the Regulation of Gene Expression in Infected Cells

Emmanuelle Bignon, Stéphanie Grandemange, Elise Dumont and Antonio Monari

J. Phys. Chem. Lett., 2023, 14, 3199
DOI: 10.1021/acs.jpclett.3c00582

Pomotrelvir and Nirmatrelvir Binding and Reactivity with SARS‐CoV‐2 Main Protease: Implications for Resistance Mechanisms from Computations

Johanna Schillings, Carlos A. Ramos‐Guzmán, J. Javier Ruiz‐Pernía and Iñaki Tuñón

Angewandte Chemie, 2024, 136
DOI: 10.1002/ange.202409527

A Reflection on the Use of Molecular Simulation to Respond to SARS-CoV-2 Pandemic Threats

Lorenzo Casalino, Carlos A. Ramos-Guzmán, Rommie E. Amaro, Carlos Simmerling, Alessio Lodola, Adrian J. Mulholland, Katarzyna Świderek and Vicent Moliner

J. Phys. Chem. Lett., 2025, 16, 3249
DOI: 10.1021/acs.jpclett.4c03654

Fluorinated Vilsmeier Reagent: TFEDMA‐mediated Synthesis of Aryl‐cyanides and Aryl‐amides via the Activation of Oximes†

Arvind K. Yadav, Srikanth Reddy Narra, Muhamad Zulfaqar Bacho, Yuji Sumii and Norio Shibata

Asian J Org Chem, 2023, 12
DOI: 10.1002/ajoc.202300049

Computational Insights into SARS-CoV-2 Main Protease Mutations and Nirmatrelvir Efficacy: The Effects of P132H and P132H-A173V

Yuan-Ling Xia, Wen-Wen Du, Yong-Ping Li, Yan Tao, Zhi-Bi Zhang, Song-Ming Liu, Yun-Xin Fu, Ke-Qin Zhang and Shu-Qun Liu

J. Chem. Inf. Model., 2024, 64, 5207
DOI: 10.1021/acs.jcim.4c00334

Unveiling the Mechanistic Singularities of Caspases: A Computational Analysis of the Reaction Mechanism in Human Caspase-1

Carlos A. Ramos-Guzmán, J. Javier Ruiz-Pernía, Kirill Zinovjev and Iñaki Tuñón

ACS Catal., 2023, 13, 4348
DOI: 10.1021/acscatal.3c00037

Testing Affordable Strategies for the Computational Study of Reactivity in Cysteine Proteases: The Case of SARS-CoV-2 3CL Protease Inhibition

Carlos A. Ramos-Guzmán, José Luis Velázquez-Libera, J. Javier Ruiz-Pernía and Iñaki Tuñón

J. Chem. Theory Comput., 2022, 18, 4005
DOI: 10.1021/acs.jctc.2c00294

Upgrading nirmatrelvir to inhibit SARS-CoV-2 Mpro via DeepFrag and free energy calculations

Nguyen Minh Tam, Trung Hai Nguyen, Minh Quan Pham, Nam Dao Hong, Nguyen Thanh Tung, Van V. Vu, Duong Tuan Quang and Son Tung Ngo

Journal of Molecular Graphics and Modelling, 2023, 124, 108535
DOI: 10.1016/j.jmgm.2023.108535

Multiscale Simulations of the Covalent Inhibition of the SARS-CoV-2 Main Protease: Four Compounds and Three Reaction Mechanisms

Bella L. Grigorenko, Igor V. Polyakov, Maria G. Khrenova, Goran Giudetti, Shirin Faraji, Anna I. Krylov and Alexander V. Nemukhin

J. Am. Chem. Soc., 2023, 145, 13204
DOI: 10.1021/jacs.3c02229

Iron-Catalyzed Cyanide-Free Synthesis of Alkyl Nitriles: Oxidative Deconstruction of Cycloalkanones with Ammonium Salts and Aerobic Oxidation

Hong Xin, Mingyu Yang, Cheng Guan, Jialong Li, Pin Gao, Xu Yang, Xin-Hua Duan and Li-Na Guo

Org. Lett., 2024, 26, 2266
DOI: 10.1021/acs.orglett.4c00458

Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332

Jian Li, Cheng Lin, Xuelan Zhou, Fanglin Zhong, Pei Zeng, Yang Yang, Yuting Zhang, Bo Yu, Xiaona Fan, Peter J. McCormick, Rui Fu, Yang Fu, Haihai Jiang, Jin Zhang and Rozanne M. Sandri-Goldin

J Virol, 2022, 96
DOI: 10.1128/jvi.02013-21

The effect of various compounds on the COVID mechanisms, from chemical to molecular aspects

Samira Mahmoudi, Mehrdad Mohammadpour Dehkordi and Mohammad Hossein Asgarshamsi

Biophysical Chemistry, 2022, 288, 106824
DOI: 10.1016/j.bpc.2022.106824

Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?

Yuan-Pin Hung, Jen-Chieh Lee, Chun-Wei Chiu, Ching-Chi Lee, Pei-Jane Tsai, I-Lin Hsu and Wen-Chien Ko

Antibiotics, 2022, 11, 220
DOI: 10.3390/antibiotics11020220

Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection

Wujun Chen, Bing Liang, Xiaolin Wu, Ling Li, Chao Wang and Dongming Xing

Journal of Pharmaceutical Analysis, 2023, 13, 255
DOI: 10.1016/j.jpha.2022.10.005

Potency Prediction of Covalent Inhibitors against SARS-CoV-2 3CL-like Protease and Multiple Mutants by Multiscale Simulations

Muya Xiong, Tianqing Nie, Zhewen Li, Meiyi Hu, Haixia Su, Hangchen Hu, Yechun Xu and Qiang Shao

J. Chem. Inf. Model., 2024, 64, 9501
DOI: 10.1021/acs.jcim.4c01594

Pharmacophore Oriented MP2 Characterization of Charge Distribution for Anti-SARS-CoV-2 Inhibitor Nirmatrelvir

Yuemin Liu, Rulong Ma, Huajun Fan, Bruce R. Johnson and James M. Briggs

Journal of Molecular Structure, 2023, 1290, 135871
DOI: 10.1016/j.molstruc.2023.135871

Mechanistic Insights into Nitrile and Alkyne Covalent Inhibitors of the SARS-CoV-2 Main Protease

Ashim Nandi, Mojgan Asadi, Aoxuan Zhang, Zhen T. Chu and Arieh Warshel

ACS Catal., 2025, 15, 1158
DOI: 10.1021/acscatal.4c06020

Paxlovid: Mechanism of Action, Synthesis, and In Silico Study

Mahrokh Marzi, Mohammad Kazem Vakil, Maryam Bahmanyar, Elham Zarenezhad and Tanveer A. Wani

BioMed Research International, 2022, 2022
DOI: 10.1155/2022/7341493

The prediction of SARS-CoV-2 main protease inhibition with filtering by position of ligand

Ya.O. Ivanova, A.I. Voronina and V.S. Skvortsov

BIOMED KHIM, 2022, 68, 444
DOI: 10.18097/pbmc20226806444

Design, synthesis and biological evaluation of covalent peptidomimetic 3CL protease inhibitors containing nitrile moiety

Mengwei Zhu, Tiantian Fu, Mengyuan You, Junyuan Cao, Hanxi Yang, Xinyao Chen, Qiumeng Zhang, Yechun Xu, Xiangrui Jiang, Leike Zhang, Haixia Su, Yan Zhang and Jingshan Shen

Bioorganic & Medicinal Chemistry, 2023, 87, 117316
DOI: 10.1016/j.bmc.2023.117316

Exploring the covalent inhibition mechanisms of inhibitors with two different warheads acting on SARS-CoV-2 Mpro by QM/MM simulations

Xiaoyue Yang, Mengguo Chen, Fanru Yuan, Jiangnan Zhang, Jinshuai Song and Longhua Yang

Computational and Theoretical Chemistry, 2024, 1242, 114979
DOI: 10.1016/j.comptc.2024.114979

Molecular Mechanism of the Non-Covalent Orally Targeted SARS-CoV-2 Mpro Inhibitor S-217622 and Computational Assessment of Its Effectiveness against Mainstream Variants

Danyang Xiong, Xiaoyu Zhao, Song Luo, John Z. H. Zhang and Lili Duan

J. Phys. Chem. Lett., 2022, 13, 8893
DOI: 10.1021/acs.jpclett.2c02428